Skip to main content
. Author manuscript; available in PMC: 2019 Aug 11.
Published in final edited form as: Lab Invest. 2019 Feb 11;99(7):1041–1048. doi: 10.1038/s41374-019-0233-x

Figure 4.

Figure 4.

Representative immunoblot analysis and quantification of TDP-43 and pTDP-43 in the insoluble protein pools of affected muscle fibers in IBM. Pathogenic pTDP-43 or truncated TDP-43 were greatly increased in both SDS and urea solubilized skeletal muscle extracts from Triton X-100 insoluble pellets from IBM patients (n=10 per group). Data are means ± s.e.m. Statistical analysis was done with student t-test. *P < 0.05, **P < 0.01.